Cargando…

Organising pneumonia caused by hormone (tamoxifen) therapy after radiotherapy for breast cancer: a case report and review of the literature

BACKGROUND: Five-year treatment with tamoxifen (TAM) has been the traditional standard of care for breast cancer. Organising pneumonia (OP) is a rare but significant complication of radiation therapy for breast cancer. The effect of TAM leading to OP has not yet been clearly documented. CASE DESCRIP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Yuting, Zhang, Yanjun, Liu, Mei, Cheng, Liuquan, Yang, Junlan, Li, Xiru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316100/ https://www.ncbi.nlm.nih.gov/pubmed/37405001 http://dx.doi.org/10.21037/atm-22-5062

Ejemplares similares

The role of magnetic resonance imaging in detection and surgical treatment of breast intraductal papillomas
por: Hao, Na, et al.
Publicado: (2019)

Proceedings: Hormones in breast cancer patients on tamoxifen.
por: Golder, M. P., et al.
Publicado: (1975)

Development and validation of a deep learning model for breast lesion segmentation and characterization in multiparametric MRI
por: Zhu, Jingjin, et al.
Publicado: (2022)

Secondary Organising Pneumonia Caused by Denosumab
por: Ouakidi, Djalaleddine, et al.
Publicado: (2023)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients
por: Ximenez, João Paulo Bianchi, et al.
Publicado: (2019)

Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.
por: Coombes, R. C., et al.
Publicado: (1982)

Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells
por: Ibrahim, Amel B., et al.
Publicado: (2019)

GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer
por: Mo, Zhiqiang, et al.
Publicado: (2013)

Tamoxifen-induced acute eosinophilic pneumonia in a breast cancer patient
por: Kwon, Eiyoung, et al.
Publicado: (2019)

Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients
por: Azria, D, et al.
Publicado: (2004)

Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
por: Yamazaki, Rena, et al.
Publicado: (2015)

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.
Publicado: (1988)

Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours
por: MacCallum, J, et al.
Publicado: (2000)

Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
por: Kojima, Nobue, et al.
Publicado: (2018)

Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data
por: Hong, Chenyan, et al.
Publicado: (2022)

Acute fibrinous and organising pneumonia: a case report and review of the literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2009)

Relation of hormones in ductal lavage fluid to age, tamoxifen treatment, and breast cancer risk
por: Chatterton, RT, et al.
Publicado: (2009)

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study
por: Heo, Jung-Yoon, et al.
Publicado: (2017)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids
por: Francini, G, et al.
Publicado: (2006)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer
por: Stone, Andrew, et al.
Publicado: (2012)

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer
por: Maselli, Angela, et al.
Publicado: (2019)

Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer
por: Kim, Eun Heui, et al.
Publicado: (2021)

Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report
por: Mirfakhraee, Sasan, et al.
Publicado: (2021)

Amiodarone: Organising pneumonia: case report
Publicado: (2021)

Tozinameran: Organising pneumonia: case report
Publicado: (2022)

Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
por: Bekele, Raie T., et al.
Publicado: (2016)

Organising Pneumonia as an Initial Manifestation of Rheumatoid Arthritis: A Case Report and Review of Literature
por: Sureja, Nayan Patel, et al.
Publicado: (2023)

Myocardial infarction risk and tamoxifen therapy for breast cancer
por: Geiger, A M, et al.
Publicado: (2005)

An epigenomic approach to therapy for tamoxifen-resistant breast cancer
por: Feng, Qin, et al.
Publicado: (2014)

Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients
por: Miranda, Carla, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer
por: Braal, C. Louwrens, et al.
Publicado: (2021)

Acute Pancreatitis Caused by Tamoxifen-Induced Severe Hypertriglyceridemia After 4 Years of Tamoxifen Use
por: Tey, Tze Tong, et al.
Publicado: (2019)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Histiocytic lymphoma of breast responds to tamoxifen.
por: Millis, R. R., et al.
Publicado: (1988)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_vjdf9ro2c2br9kovihsarhcuia